Floatz logo

Imc-1

Fibromyalgia

Innovative Med Concepts, LLCUNKNOWNPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Fibromyalgia cohort.

Asset / SponsorPhaseRating
Duloxetine
Cukurova University
Phase 4BBB
Pregabalin
Yung Shin Pharm. Ind. Co., Ltd.
Phase 4BB
Piperazine, 1-(Bis(4-Fluorophenyl)Methyl)-4-(3-Phenyl-2-Propenyl)-, (E)-
Taipei Veterans General Hospital, Taiwan
Phase 4BB
Lidocaine
Peking University Third Hospital
Phase 2BB
Mirogabalin
Daiichi Sankyo
Phase 3B

View all 33 →

Same molecule, other indications

Imc-1 is also rated in:

myofascial pain syndromeDormant
B
Indicative · Phase 2
57 / 100
View asset →
chronic pain syndromeDormant
CCC
Indicative · Phase 2
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →